Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.564EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.461EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.486EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.603EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.606EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.601EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.186EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.324EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.213EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.341EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.204EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.170EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.232EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.84EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.269EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.234EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Z.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
V.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.282EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.131EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.274EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.235EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.165EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.243EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
R.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.216EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.471EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.518EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.551EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used